JUPITER-06 Final Overall Survival and Genomic Biomarker Analysis in Advanced ESCC
PICI Collaborates with ASCO to Support Future Leaders in Cancer Immunotherapy
In Memory of Kirsty Duncan: A Life Devoted to Science, Health, and Equity
FDA Approves Daratumumab (Darzalex Faspro) Plus VRd for Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Pat Soon-Shiong: The Beginning of the Paradigm Change in Cancer
Cervical Cancer Screening’s Global Evolution: From Pap Smears to HPV Testing
Institute of Oncology Ljubljana Opens Slovenia’s First Department of Clinical Nutrition and Gastrointestinal Failure
Fabio Ynoe de Moraes has been Named Deputy Editor of JCO Global Oncology
The public meeting, "Modernizing Oncology Endpoints: Pathways for Evidence and Policy," hosted by Friends of Cancer Research, is scheduled for Thursday, February 5, 2026, from 9:30 AM to 2:00 PM ET. This event, which will be held at The Ritz-Carlton in Washington, DC, and streamed virtually, is focused on reviewing the current landscape and application […]
The public meeting, "Application of External Control Arms in Oncology Drug Development," hosted by Friends of Cancer Research, is scheduled for Tuesday, April 7, 2026, from 10:00 AM to 2:00 PM ET, at The Ritz-Carlton in Washington, DC, with a virtual streaming option available. The purpose of the meeting is to explore opportunities for advancing […]
The public meeting, "Unlocking Next-Generation Therapies," is an event co-hosted by Friends of Cancer Research and the Parker Institute for Immunotherapy (PICI), scheduled for Wednesday, May 6, 2026, from 10:00 AM to 2:00 PM ET. Held at The Ritz-Carlton in Washington, DC, with a virtual option, the meeting will gather experts to explore innovative approaches […]
